Literature DB >> 17596638

Light treatment for neuropsychiatric behaviors in Alzheimer's disease.

Glenna A Dowling1, Carla L Graf, Erin M Hubbard, Jay S Luxenberg.   

Abstract

Neuropsychiatric behaviors are common in people with Alzheimer's disease (AD) and make both professional and lay caregiving difficult. Light therapy has been somewhat successful in ameliorating disruptive behaviors. This randomized trial tested the effects of morning or afternoon bright light exposure compared with usual indoor light on the presence, frequency, severity, and occupational disruptiveness of neuropsychiatric behaviors in nursing home residents with AD. Light was administered for 1 hr daily (Monday-Friday) for 10 weeks. The Neuropsychiatric Inventory-Nursing Home was used to assess behavior at baseline and end of the intervention. Analyses revealed statistically significant differences between groups on agitation/aggression, depression/dysphoria, aberrant motor behavior, and appetite/eating disorders. The magnitude of change was small and may not represent clinically significant findings. Agitation/aggression and nighttime behaviors commonly occurred and were highly correlated with occupational disruptiveness. Interventions that decrease the presence and/or severity of neuropsychiatric behaviors have the potential to significantly decrease caregiver burden.

Entities:  

Mesh:

Year:  2007        PMID: 17596638      PMCID: PMC2387134          DOI: 10.1177/0193945907303083

Source DB:  PubMed          Journal:  West J Nurs Res        ISSN: 0193-9459            Impact factor:   1.967


  25 in total

1.  Measuring change in psychiatric symptoms using the Neuropsychiatric Inventory: Nursing Home version.

Authors:  Grant L Iverson; Grace A Hopp; Kimberley DeWolfe; Kevin Solomons
Journal:  Int J Geriatr Psychiatry       Date:  2002-05       Impact factor: 3.485

2.  The use of the neuropsychiatric inventory in nursing home residents. Characterization and measurement.

Authors:  S Wood; J L Cummings; M A Hsu; T Barclay; M V Wheatley; K T Yarema; J F Schnelle
Journal:  Am J Geriatr Psychiatry       Date:  2000       Impact factor: 4.105

3.  Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.

Authors:  Peter Paul De Deyn; Ira R Katz; Henry Brodaty; Benjamin Lyons; Andrew Greenspan; Alistair Burns
Journal:  Clin Neurol Neurosurg       Date:  2005-10       Impact factor: 1.876

4.  Psychotropic drug use in nursing homes--diagnostic indications and variations between institutions.

Authors:  S Ruths; J Straand; H A Nygaard
Journal:  Eur J Clin Pharmacol       Date:  2001-09       Impact factor: 2.953

5.  The impact of neuropsychiatric symptoms of dementia on distress in family and professional caregivers in Singapore.

Authors:  Lay Ling Tan; Hwee Bee Wong; Harry Allen
Journal:  Int Psychogeriatr       Date:  2005-06       Impact factor: 3.878

6.  Effect of light treatment on sleep and circadian rhythms in demented nursing home patients.

Authors:  Sonia Ancoli-Israel; Jennifer L Martin; Daniel F Kripke; Matthew Marler; Melville R Klauber
Journal:  J Am Geriatr Soc       Date:  2002-02       Impact factor: 5.562

7.  Patient and caregiver characteristics and nursing home placement in patients with dementia.

Authors:  Kristine Yaffe; Patrick Fox; Robert Newcomer; Laura Sands; Karla Lindquist; Kyle Dane; Kenneth E Covinsky
Journal:  JAMA       Date:  2002-04-24       Impact factor: 56.272

8.  Effect of light on agitation in institutionalized patients with severe Alzheimer disease.

Authors:  Sonia Ancoli-Israel; Jennifer L Martin; Philip Gehrman; Tamar Shochat; Jody Corey-Bloom; Matthew Marler; Sarah Nolan; Leah Levi
Journal:  Am J Geriatr Psychiatry       Date:  2003 Mar-Apr       Impact factor: 4.105

9.  Effect of timed bright light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease.

Authors:  Glenna A Dowling; Judy Mastick; Erin M Hubbard; Jay S Luxenberg; Robert L Burr
Journal:  Int J Geriatr Psychiatry       Date:  2005-08       Impact factor: 3.485

Review 10.  Light therapy for managing sleep, behaviour, and mood disturbances in dementia.

Authors:  D Forbes; D G Morgan; J Bangma; S Peacock; N Pelletier; J Adamson
Journal:  Cochrane Database Syst Rev       Date:  2004
View more
  19 in total

Review 1.  Circadian Disruption Associated with Alzheimer's Disease.

Authors:  Yumna Saeed; Sabra M Abbott
Journal:  Curr Neurol Neurosci Rep       Date:  2017-04       Impact factor: 5.081

Review 2.  Light therapy and Alzheimer's disease and related dementia: past, present, and future.

Authors:  Nicholas Hanford; Mariana Figueiro
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

3.  Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light--a randomized clinical trial.

Authors:  Els I S Most; Philip Scheltens; Eus J W Van Someren
Journal:  Trials       Date:  2010-02-23       Impact factor: 2.279

4.  Positive effect of timed blue-enriched white light on sleep and cognition in patients with mild and moderate Alzheimer's disease.

Authors:  Seong Jae Kim; Sun Hee Lee; In Bum Suh; Jae-Won Jang; Jin Hyeong Jhoo; Jung Hie Lee
Journal:  Sci Rep       Date:  2021-05-13       Impact factor: 4.379

Review 5.  A systematic mapping review of randomized controlled trials (RCTs) in care homes.

Authors:  Adam L Gordon; Phillipa A Logan; Rob G Jones; Calum Forrester-Paton; Jonathan P Mamo; John R F Gladman
Journal:  BMC Geriatr       Date:  2012-06-25       Impact factor: 3.921

Review 6.  Protecting the melatonin rhythm through circadian healthy light exposure.

Authors:  Maria Angeles Bonmati-Carrion; Raquel Arguelles-Prieto; Maria Jose Martinez-Madrid; Russel Reiter; Ruediger Hardeland; Maria Angeles Rol; Juan Antonio Madrid
Journal:  Int J Mol Sci       Date:  2014-12-17       Impact factor: 5.923

Review 7.  Nonpharmacological Interventions to Reduce Behavioral and Psychological Symptoms of Dementia: A Systematic Review.

Authors:  Alexandra Martini de Oliveira; Marcia Radanovic; Patrícia Cotting Homem de Mello; Patrícia Cardoso Buchain; Adriana Dias Barbosa Vizzotto; Diego L Celestino; Florindo Stella; Catherine V Piersol; Orestes V Forlenza
Journal:  Biomed Res Int       Date:  2015-11-29       Impact factor: 3.411

8.  Morning light therapy for juvenile depression and severe mood dysregulation: study protocol for a randomized controlled trial.

Authors:  Sarah Bogen; Tanja Legenbauer; Thorsten Bogen; Stephanie Gest; Thomas Jensch; Silvia Schneider; Martin Holtmann
Journal:  Trials       Date:  2013-06-17       Impact factor: 2.279

9.  Expert Consensus on the Care and Management of Patients with Cognitive Impairment in China.

Authors:  Yuliang Han; Jianjun Jia; Xia Li; Yang Lv; Xuan Sun; Shanshan Wang; Yongjun Wang; Zhiwen Wang; Jintao Zhang; Jiong Zhou; Yuying Zhou
Journal:  Neurosci Bull       Date:  2019-12-02       Impact factor: 5.271

Review 10.  Optimal nonpharmacological management of agitation in Alzheimer's disease: challenges and solutions.

Authors:  José Carlos Millán-Calenti; Laura Lorenzo-López; Begoña Alonso-Búa; Carmen de Labra; Isabel González-Abraldes; Ana Maseda
Journal:  Clin Interv Aging       Date:  2016-02-22       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.